Turning Regulatory Activity Into Actionable Intelligence

Regulatory agencies generate enormous amounts of information, from product approvals and clearances to recalls, inspections, warning letters, guidance documents, regulations, and enforcement actions.

Individual developments matter. But their greatest value often comes from understanding how they fit together.

MDP Regulatory Intelligence goes beyond reporting regulatory activity to identify patterns, emerging trends, changing risks, and developments that may affect regulated organizations. By combining structured regulatory data, historical analysis, ongoing monitoring, and professional interpretation, we help turn regulatory information into practical intelligence.

Our Regulatory Intelligence resources are organized around five primary areas.

Market Authorization Intelligence

Track what is entering the market and how regulatory pathways are evolving.

Our analysis includes 510(k) clearances, De Novo authorizations, PMAs and PMA supplements, drug and biologic approvals, review activity, product categories, companies, and historical trends.

Explore Market Authorization Intelligence

Enforcement Intelligence

FDA enforcement activity provides an important window into emerging compliance risks.

We monitor and analyze warning letters, recalls, import actions, FSVP enforcement, and other compliance actions to identify recurring deficiencies, changing enforcement priorities, and lessons for regulated organizations.

Explore Enforcement Intelligence

Inspection & Compliance Intelligence

Inspection outcomes can reveal how regulatory expectations are being applied in practice.

MDP tracks FDA inspection activity, compliance classifications, QMSR implementation, inspection trends, and other indicators that can help organizations better understand the evolving compliance environment.

Explore Inspection & Compliance Intelligence

Policy & Regulatory Change

Regulatory requirements are continually shaped by Congress, FDA rulemaking, guidance documents, agency programs, and changing regulatory policy.

We follow these developments with an emphasis on what changed, who is affected, when it matters, and what regulated organizations should be considering next.

Explore Policy & Regulatory Change

Industry & Technology Intelligence

Regulatory data can also reveal where innovation is occurring.

MDP examines activity across companies, therapeutic areas, product codes, countries, and emerging technologies, including artificial intelligence, digital health, medical robotics, diagnostics, and other rapidly developing areas.

Explore Industry & Technology Intelligence

From Data to Understanding

MDP Regulatory Intelligence draws on current regulatory activity and historical data to distinguish meaningful developments from normal variation.

Our analysis may include monthly and year-to-date activity, rolling trends, historical comparisons, review timelines, technology patterns, company activity, geographic trends, and other indicators. As our Regulatory Intelligence resources expand, this hub will provide access to data analysis, recurring intelligence reports, regulatory dashboards, research, and professional insights.

The objective is not simply to tell you what happened. It is to help you understand what it means, and what may be coming next.